DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Chronic Bronchitis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Chronic Bronchitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chronic Bronchitis development. The report provides ...
January 2020
60 pages
Chronic Pancreatitis Pain - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Pancreatitis Pain The report also ...
January 2020
60 pages
Chronic Urticaria Or Hives - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Urticaria Or Hives The report also ...
January 2020
90 pages
Cryptococcosis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Cryptococcosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cryptococcosis development. The report provides detailed ...
January 2020
60 pages
Dental Pain - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Dental Pain - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dental Pain development. The report provides ...
January 2020
60 pages
Dystonia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Dystonia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dystonia development. The report provides detailed ...
January 2020
60 pages
Emphysema - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Emphysema - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Emphysema development. The report provides detailed ...
January 2020
60 pages
Equine Encephalitis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Equine Encephalitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Equine Encephalitis development. The report provides ...
January 2020
60 pages
Familial Adenomatous Polyposis Coli - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Familial Adenomatous Polyposis Coli The report also ...
January 2020
120 pages
Guillain-Barre Syndrome - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Guillain-Barre Syndrome - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Guillain-Barre Syndrome development. The report provides ...
January 2020
60 pages
H1N1 infection - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'H1N1 infection - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across H1N1 infection development. The report provides ...
January 2020
60 pages
H3N2 Infection - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'H3N2 Infection - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across H3N2 Infection development. The report provides ...
January 2020
90 pages
Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Hematopoietic Stem Cell Transplantation The report also ...
January 2020
60 pages
Hemophilia B - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Hemophilia B - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hemophilia B development. The report provides ...
January 2020
90 pages
Hemorrhagic Shock - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Hemorrhagic Shock - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hemorrhagic Shock development. The report provides ...
January 2020
60 pages
Hemostasis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Hemostasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hemostasis development. The report provides detailed ...
January 2020
60 pages
Hepatic Tumor - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Hepatic Tumor - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hepatic Tumor development. The report provides ...
January 2020
90 pages
Hot Flashes - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Hot Flashes - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hot Flashes development. The report provides ...
January 2020
90 pages
Human papillomavirus (HPV) Associated Cancer - Pipeline Insight, 2020
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Human papillomavirus (HPV) Associated Cancer The report also ...
January 2020
90 pages
Hyperalgesia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Hyperalgesia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hyperalgesia development. The report provides detailed ...
January 2020
60 pages
Hyperkalemia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Hyperkalemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hyperkalemia development. The report provides detailed ...
January 2020
60 pages
Hyperparathyroidism - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Hyperparathyroidism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hyperparathyroidism development. The report provides detailed ...
January 2020
60 pages
